Instituto Alexander Fleming, Buenos Aires, Argentina; Instituto Oncología Angel H. Roffo, Buenos Aires, Argentina.
Instituto Alexander Fleming, Buenos Aires, Argentina; Instituto Oncología Angel H. Roffo, Buenos Aires, Argentina.
J Plast Reconstr Aesthet Surg. 2021 May;74(5):1061-1070. doi: 10.1016/j.bjps.2020.10.062. Epub 2020 Nov 7.
Dermatofibrosarcoma protuberans (DFSP) is a rare, low-grade mesenchymal skin tumor. Complete surgical excision remains the mainstay of treatment. Head and neck (HN) DFSP features high local recurrence (LR) rates with wide local excision (WLE) due to both anatomical limitations and functional and cosmetic concerns. Mohs micrographic surgery (MMS) allows complete margin control and is particularly suitable for HN-DFSPs.
Between 2000 and 2018, 103 DFSP were managed with MMS; 41 (39.8%) were in the HN. Our case series included 23 females (56.1%); mean age: 44.5 yrs. The most frequent sites were the supraclavicular area (10) and forehead (9). Mean size: 5.1 cm (6-16). Previous surgery: 43.9%. We have used permanent-tissue MMS (27 cases) since 2006.
Mean first layer lateral margin: 1.6 cm. Negative margins after first and second stage: 51.2% and 92.7%, respectively. Mean follow-up: 92.6 months (16-225). LR: 1(2.4%). We observed no regional or distant metastasis.
We conducted a literature search in PubMed for HN-DFSP and found that this seems to be the largest published series to date. In terms of LR, a substantial difference between WLE 62.5% (9-73%) and MMS 0.8% (0-2.4%) was seen. Forty-one HN-DFSP with unfavorable prognostic factors (mean size: 5.1 cm, previous treatment: 43.9%) were treated. LR: 1(2.4%). Mean follow-up: 92.6 months. Randomized controlled trials are needed, though not likely to be conducted, mainly because of the rarity of HN-DFSP, the need for a long follow-up, and the lack of MMS availability in some institutions. We consider MMS to be the standard treatment for HN-DFSP due to its high cure rate and tissue sparing. Modified WLE with complete margin control appears to be a comparable strategy.
隆突性皮肤纤维肉瘤(DFSP)是一种罕见的、低度恶性的间叶组织皮肤肿瘤。完整的外科切除仍然是主要的治疗方法。由于解剖限制以及功能和美容方面的考虑,头颈部(HN)DFSP 在广泛局部切除(WLE)后具有较高的局部复发(LR)率。Mohs 显微外科手术(MMS)可实现完全边缘控制,特别适用于 HN-DFSP。
2000 年至 2018 年间,我们采用 MMS 治疗了 103 例 DFSP,其中 41 例(39.8%)位于 HN。我们的病例系列包括 23 名女性(56.1%);平均年龄:44.5 岁。最常见的部位是锁骨上区(10 例)和前额(9 例)。平均大小:5.1cm(6-16cm)。既往手术:43.9%。自 2006 年以来,我们一直使用永久性组织 MMS(27 例)。
第一层侧向边缘的平均宽度为 1.6cm。第一阶段和第二阶段的阴性边缘分别为 51.2%和 92.7%。平均随访时间:92.6 个月(16-225 个月)。LR:1(2.4%)。我们未观察到区域性或远处转移。
我们在 PubMed 中对头颈部 DFSP 进行了文献检索,发现这似乎是迄今为止发表的最大系列。就 LR 而言,WLE 为 62.5%(9-73%),MMS 为 0.8%(0-2.4%),两者之间存在显著差异。41 例具有不良预后因素的 HN-DFSP(平均大小:5.1cm,既往治疗:43.9%)接受了治疗。LR:1(2.4%)。平均随访时间:92.6 个月。尽管不太可能进行,但需要进行随机对照试验,主要是因为 HN-DFSP 罕见,需要长期随访,以及某些机构缺乏 MMS 可用性。我们认为 MMS 是 HN-DFSP 的标准治疗方法,因为它具有高治愈率和组织保留率。具有完整边缘控制的改良 WLE 似乎是一种具有可比性的策略。